Akèy › Twoub depresif majè › Pennsylvania
Etid klinik pou Twoub depresif majè nan Pennsylvania
27 etid pou Twoub depresif majè ap chèche patisipan nan sit nan Pennsylvania.
Vil nan Pennsylvania
Tèks ofisyèl etid la (Anglè)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Adams Clinical Philadelphia, Philadelphia
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Oct 1, 2026 · NCT07775300Precision Depression Adalimumab Trial
- University of Pennsylvania, Philadelphia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT07845604Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- University of Pennsylvania, Philadelphia
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 25, 2026 · NCT06559306Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- University of Pennsylvania - Perelman School of Medicine, Philadelphia
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Adams Clinical Philadelphia, Philadelphia
- Flourish Research Philadelphia, Philadelphia
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Allentown
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 14, 2026 · NCT07065240Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
- University of Pennsylvania, Philadelphia
Ap rekriteFaz 1 bonè
Laj 25 a 65 · Tout sèks · Mizajou Sep 10, 2026 · NCT06788249Decoding and Modulating Affective Brain States
- University of Pennsylvania, Philadelphia
Ap rekriteMande peman pou patisipan yo
Laj 18 a 65 · Tout sèks · Mizajou Sep 3, 2026 · NCT05437705A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Allentown
- Draig Clinical Site, Media
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Pennsylvania Hospital, Philadelphia
Ap rekrite
Laj 22 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Media
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07226232A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Adams Clinical Philadelphia, Philadelphia
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 10, 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Suburban Research Associates, Media
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Lehigh Center For Clinical Research, Allentown
- Adams Clinical - Philadelphia, Philadelphia
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Aug 3, 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Lehigh Center for Clinical Research, Allentown
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Aug 3, 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Lehigh Center for Clinical Research, Allentown
- Adams Clinical, Philadelphia
Ap rekriteFaz 2
Laj 18 a 64 · Tout sèks · Mizajou Jul 27, 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Philadelphia
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401Rapid Antidepressant Dynamics in Acute Neuromodulation Treatments
- Bellefield Towers, Pittsburgh
Ap rekrite
Laj 18 a 55 · Tout sèks · Mizajou May 22, 2026 · NCT06976840Triage Survey for Psychiatry Research Eligibility
- Adams Clinical, Philadelphia, Philadelphia
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT05800925A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Scranton Medical Institute, LLC, Moosic
- University of Pennsylvania, Philadelphia
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
- University of Pittsburgh, Pittsburgh
Ap rekrite
Laj 18 a 55 · Tout sèks · Mizajou Mar 4, 2026 · NCT05703256Taking Action for College Students
- Temple University, Philadelphia
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 29, 2025 · NCT06700902Neurofeedback to Treat Depression - 2
- Center for Neuromodulation in Depression and Stress, Philadelphia
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Dec 4, 2025 · NCT07159061Study of ALTO-300 in MDD
- Site 216, Allentown
- Site 350, Media
- Site 352, Moosic
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jul 24, 2025 · NCT05922878Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.